Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -96.69% | $ 4.56M | $ 4.41M |
3/31/2025 | -185.45% | $ 4.77M | $ 8.85M |
12/31/2024 | -90.06% | $ 6.58M | $ 5.93M |
9/30/2024 | -118.54% | $ 6.17M | $ 7.32M |
6/30/2024 | -93.19% | $ 8.25M | $ 7.69M |
3/31/2024 | -10.17% | $ 14.13M | $ 1.44M |
12/31/2023 | -11.68% | $ 10.04M | $ 1.17M |
9/30/2023 | 0% | $ 12.9M | $ 0 |
6/30/2023 | 0% | $ 13.86M | $ 0 |
3/31/2023 | 0% | $ 15.08M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for VIVOSIM LABS INC is calculated as follows: (-1 * CF - Equity [ $ 13K ]) / Market Cap [ $ 69.74M ]
(=) Buyback Yield [ -0.02% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.71% |